United Nations Environment Programme
   Ozone Secretariat

Search
Handbook for the Montreal Protocol on Substances
that Deplete the Ozone Layer - 7th Edition (2006)
Sections   Section One The Montreal
Protocol
Section Two Decisions Section Three Annexes Section Four Rules of
Procedure
Section Five Sources of Further
Information
General Index General
Index
PreviousPrevious Next Next

Decisions on essential uses: metered-dose inhalers (MDIs)

Decision VIII/10: Actions by Parties not operating under Article 5 to promote industry’s participation on a smooth and efficient transition away from CFC-based MDIsDecision VIII/11: Measures to facilitate a transition by a Party not operating under Article 5 from CFC-based MDIsDecision VIII/12: Information gathering on a transition to non-CFC treatments for asthma and chronic obstructive pulmonary disease for Parties not operating under Article 5
Decision IX/19: Metered-dose inhalers (MDIs)Decision IX/20: Transfer of essential-use authorizations for CFCs for MDIsDecision XII/2: Measures to facilitate the transition to chlorofluorocarbon-free metered-dose inhalers
Decision XIII/9: Metered-dose inhaler (MDI) productionDecision XIII/10: Further study of campaign production of CFCs for metered-dose inhalers (MDIs)Decision XIV/5: Global database and assessment to determine appropriate measures to complete the transition from chlorofluorocarbon metered-dose inhalers
Decision XV/5: Promoting the closure of essential-use nominations for metered-dose inhalersDecision XVII/14: Difficulties faced by some Parties operating under paragraph 1 of Article 5 of the Montreal Protocol with respect to chlorofluorocarbons used in the manufacture of metered-dose inhalers

 

PreviousPrevious Next Next
Sections   Section One The Montreal
Protocol
Section Two Decisions Section Three Annexes Section Four Rules of
Procedure
Section Five Sources of Further
Information
General Index General
Index
Front Cover Foreword Introduction Contents Back Cover

 

  © Ozone Secretariat 2004